Form4insider filings, from the source

SEC Form 4 · accession 0001658918-26-000014

MapLight Therapeutics, Inc. · MPLT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Christopher A. Kroeger
Officer — Chief Executive Officer · Director
Period of report
Jul 15, 2026
Accepted (ET)
Jul 17, 2026 · 9:46 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001770069

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Voting Common StockF1,F2Jul 15, 2026S18,950$36.00D1,375,144D
Voting Common StockF1,F3Jul 15, 2026S42,738$36.99D1,332,406D
Voting Common StockF1Jul 15, 2026S90$37.54D1,332,316D
Voting Common StockF1,F4Jul 16, 2026S40,899$36.46D1,291,417D
Voting Common StockF1,F5Jul 16, 2026S28,091$37.26D1,263,326D
Voting Common StockF1Jul 16, 2026S92$37.96D1,263,234D
Voting Common StockF1,F6Jul 17, 2026S16,779$37.90D1,246,455D
Voting Common StockF7holding———101,190ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses